2,172
Participants
Start Date
April 1, 2019
Primary Completion Date
November 1, 2024
Study Completion Date
November 1, 2025
Docetaxel
Docetaxel chemotherapy (injection)
Cyclophosphamide
Cyclophosphamide chemotherapy (injection)
RECRUITING
The First Hospital of China Medical University, Shenyang
RECRUITING
The Second Hospital of Dalian Medical University, Dalian
RECRUITING
The First Bethune Hospital of Jilin University (The First Hospital of Jilin University), Changchun
RECRUITING
Harbin Medical University Cancer Hospital, Harbin
RECRUITING
OB/GYN Hospital of Fudan University, Shanghai
RECRUITING
Fudan University Shanghai Cancer Hospital, Shanghai
RECRUITING
The Affiliated Hospital of Qingdao University, Qingdao
RECRUITING
Tianjin Medical University Cancer Institute and Hospital, Tianjin
RECRUITING
The First Affiliated Hospital, ZheJiang University, Hangzhou
RECRUITING
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hanzhou
RECRUITING
Zhejiang Cancer Hospital, Hangzhou
RECRUITING
Fujian Medical University Union Hospital, Fuzhou
RECRUITING
Chongqing Cancer Hospital, Chongqing
RECRUITING
Sun Yet-Sen Memorial Hospital, Sun Yet-Sen University, Guangzhou
Fudan University
OTHER